Sai Kit LamDonald BurkeMaria Rosario CapedingChee Keong ChongLaurent CoudevilleJeremy FarrarDuane GublerSri Rezeki HadinegoroJeffrey HannaJean LangHan Lim LeeYee Sin LeoChan Quang LuongRichard MahoneyJohn McbrideJorge Mendez-GalvanLee Ching NgSuchitra NimmannityaEng Eong OoiDonald ShepardJaco SmitRémy TeyssouLaurent ThomasJoseph TorresiPedro VasconcelosDewa Nyoman WirawanSutee YoksanUniversity of MalayaUniversity of Pittsburgh Graduate School of Public HealthGokilaKementerian Kesihatan MalaysiaSanofi PasteurUniversity of OxfordNational University of SingaporeMinistry of Health, Republic of IndonesiaTropical Population Health UnitInstitute for Medical Research Kuala LumpurTan Tock Seng HospitalPasteur Institute in Ho Chi Minh CityInternational Vaccine Institute, SeoulJames Cook University, AustraliaHospital Infantil de Mexico Federico GomezNational Environmental AuthorityThailand Ministry of Public HealthBrandeis UniversityEmergency Network at the University Hospital of Fort-de-FranceAustin Center for Infection ResearchInstituto Evandro ChagasSchool of PublicMahidol University2018-05-032018-05-032011-11-28Vaccine. Vol.29, No.51 (2011), 9417-9422187325180264410X2-s2.0-81955164742https://repository.li.mahidol.ac.th/handle/20.500.14594/11426Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to control dengue and several candidate vaccines are in development. Experts in dengue and in vaccine introduction gathered for a two day meeting during which they examined the challenges inherent to the introduction of a dengue vaccine into the national immunisation programmes of countries of the Asia-Pacific. The aim was to develop a series of recommendations to reduce the delay between vaccine licensure and vaccine introduction. Major recommendations arising from the meeting included: ascertaining and publicising the full burden and cost of dengue; changing the perception of dengue in non-endemic countries to help generate global support for dengue vaccination; ensuring high quality active surveillance systems and diagnostics; and identifying sustainable sources of funding, both to support vaccine introduction and to maintain the vaccination programme. The attendees at the meeting were in agreement that with the introduction of an effective vaccine, dengue is a disease that could be controlled, and that in order to ensure a vaccine is introduced as rapidly as possible, there is a need to start preparing now. © 2011 Elsevier Ltd.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineVeterinaryReviewSCOPUS10.1016/j.vaccine.2011.08.047